Interaction of platinum-based cytostatics and platinum nanoparticles with metallothionein - potencial source of the antitumor drug resistence
Loading...
Date
2018-03-31
ORCID
Advisor
Referee
Mark
Journal Title
Journal ISSN
Volume Title
Publisher
TANGER
Abstract
Platinum-based cytostatic represent a unique class of DNA-damaging antitumor agents and they are one the
most frequently used drugs in oncology. Problem is that some kind of cancer is resistant against this type of
cytostatics. This resistance can be potentially caused by metalloproteins such as metallothioneins. MTs belong
to the group of intracellular cystine-rich, metal-binding proteins and hold a number of functions in body. One
of them is detoxification of heavy metals. This ability of MTs can cause a decreased therapeutic effect of
platinum-based cytostatics. In this work, the interaction between two isoforms of MTs (MT3 and MT2a) and
several types of platinum cytostatics (oxaliplatin, carboplatin and cisplatin) as well as platinum nanoparticles
(size of 10 and 40 nm) was examined by fluorimetric analysis using a fluorescence zinc indicator (Fluozin-3).
Both, stationary fluorescence spectrometry and capillary electrophoresis with laser-induced fluorescence
detection (ex - 488 nm, em - 530 nm) was used in the study.
Description
Citation
Document type
Peer-reviewed
Document version
Published version
Date of access to the full text
Language of document
en
Study field
Comittee
Date of acceptance
Defence
Result of defence
Document licence
(C) TANGER